Beacon Medical Interchange

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Beacon Medical Interchange

beaconmedic.com

Lung
Testicular
Prostate
Renal Cell
Bladder
Gastrointestinal
General

Playback speed

10 seconds

Pembrolizumab for PS2 Patients with Adv. NSCLC: Results of the PePS2 Trial

By Beacon Medical Interchange FEATURING Jack West

0 views

November 16, 2018

Dr. Jack West summarizes new information presented at ESMO 2018 on the PePS2 trial of ...
read more ↘ pembrolizumab (Keytruda) in patients with advanced NSCLC performance status (PS) of 2, which demonstrated favorable efficacy and no concerning challenges with toxicity in this population.
↖ read less

Comments 0